Eric Lawitz, MD
Enriched profileClinical Professor of Medicine; Medical Director, Texas Liver Institute; Vice President, Scientific and Research Development, Texas Liver Institute · Texas Liver Institute
Eric Lawitz is Clinical Professor of Medicine; Medical Director, Texas Liver Institute; Vice President, Scientific and Research Development, Texas Liver Institute at Texas Liver Institute. OpenAlex indexes 548 publications with 43,874 citations (h-index 93); ClinicalTrials.gov lists 17 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Gastroenterology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 13 Oct 2026
Eric J. Lawitz, MD, is Clinical Professor of Medicine at Texas Liver Institute / UT Health San Antonio (Long School of Medicine, Division of Gastroenterology). The public record shows 548 publications with 43,874 citations (h-index 93), centered on Hepatitis C virus research, Liver Disease Diagnosis and Treatment, HIV/AIDS drug development and treatment. It also documents an investigator role on 17 registered clinical trials, industry payments reported by 23 companies.
- Most recent indexed publication: 2026 · Alimentary pharmacology & therapeutics
- Top research focus: Hepatitis C virus research
- 17 registered trials on ClinicalTrials.gov
- Open Payments reporting from 23 companies
Generated from the cited public record · current as of 13 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 7 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 252.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 13 Oct 2026
Listed as an investigator on 17 registered studies on ClinicalTrials.gov. The most recent:
- A Study of Efimosfermin Alfa in Adults With Hepatic Impairment
Sponsor: GlaxoSmithKline
- A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
Sponsor: Eli Lilly and Company
Industry payments
Updated 13 Oct 2026
23 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year202534 payments$80,358openpaymentsdata.cms.gov ↗
- Gilead Sciences, Inc.Program year202535 payments$35,646openpaymentsdata.cms.gov ↗
- Ipsen Biopharmaceuticals, IncProgram year202513 payments$24,711openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
57.3%Bile Acid35.2%Ursodiol100%Part D≥51 patientsOsmotic Laxative17.4%Lactulose48%Constulose36%Enulose16%Part D<11 patients+ 2 more classes in this area
Cardiovascular
22.3%Aldosterone antagonist (MRA)9.7%Spironolactone100%Part D≥22 patientsLoop diuretic7.9%Furosemide100%Part D≥25 patients+ 1 more class in this area
Cancer & immunology
10.5%Purine Antimetabolite10.5%Azathioprine100%Part D≥20 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 13 Oct 2026
4 congress contributions (2019–2021) across ADA, ENDO per OpenAlex. The most recent:
- BIO89-100 Demonstrated Robust Reductions in Liver Fat and Liver Fat Volume (LFV) by MRI-PDFF, Favorable Tolerability and Potential for Weekly (QW) or Every 2 Weeks (Q2W) Dosing in a Phase 1b/2a Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in NASH
ENDO Annual Meeting
ENDO2021Co-author - 1850-P: High Prevalence of Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis (NASH): The Impact on Patient-Reported Outcomes (PROs)
ADA Scientific Sessions
ADA2020Co-authorPoster
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 13 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Editorial: Combination Therapies for MASH: A Step Forward or More Complexity? Authors' Reply.
Alimentary pharmacology & therapeutics
Editorial2026 - Changes in liver enzymes and cardiometabolic markers in individuals with obesity and metabolic-dysfunction-associated steatohepatitis treated with semaglutide.
Current medical research and opinion
Article2025 - Effect of Target-Mediated Disposition on Iptacopan Clinical Pharmacokinetics in Participants with Normal or Impaired Hepatic Function.
Clinical pharmacology and therapeutics
Clinical Trial2025 - Safety, pharmacokinetics and pharmacodynamics of obeticholic acid in subjects with fibrosis or cirrhosis from NASH.
Liver international
Clinical Trial2024
Most-cited works
by citation count (OpenAlex)- 01Treatment of HCV Infection by Targeting MicroRNA2,188 citations2013
- 02Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection1,783 citations2013
- 03Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection1,615 citations2011
- 04Telaprevir for Retreatment of HCV Infection1,537 citations2011
- 05Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection1,308 citations2014
Network
Updated 13 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 13 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/eric-lawitz-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Eric-Lawitz-2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - LinkedIn
linkedin.com/in/eric-lawitz-6941a28
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - Other
muckrack.com/eric-lawitz
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →muckrack.com ↗
Mentions by others
where others cite or feature them- Other
txliver.com/edu-videos/introduction-to-your-liver-by-dr-eric-lawitz
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →txliver.com ↗ - Facebook
facebook.com/story.php
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →facebook.com ↗ - Other
healio.com/news/infectious-disease/20140313/j467_0101_24_news_print_2
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healio.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 13 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.uthscsa.edu ↗
- B.S.
University of Illinois at Chicago
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.uthscsa.edu ↗ - Fellowship
Gastroenterology/Hepatology, Brooke Army Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.uthscsa.edu ↗ - Board certified
Gastroenterology/Hepatology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.uthscsa.edu ↗
Editorial & leadership roles
journal and society appointments- Member
American Association for the Study of Liver Diseases (AASLD)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healio.com ↗ - Member
American College of Gastroenterology (ACG)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healio.com ↗ - Member
American Gastroenterological Association (AGA)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healio.com ↗ - Member
Association of Clinical Research Professionals (ACRP)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healio.com ↗ - Member
European Association for the Study of the Liver (EASL)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healio.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.uthscsa.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.uthscsa.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.uthscsa.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.uthscsa.edu ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →prnewswire.com ↗
- Prior 11-year career at Brooke Army Medical Center
Dept. of Gastroenterology and Hepatology (Chief of Clinical Services; Medical Director, Viral Hepatitis Clinic; GI Associate Program Director)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healio.com ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →txliver.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Charles Rice, MD
The Rockefeller University
Kris Kowdley, MD
Washington State University
Eamonn Quigley, MD
Houston Methodist Hospital and Academic Institute
Patrick Kamath, MD
Mayo Clinic